“Drug warning!” blares the voice from a late-night TV ad. “Have you or a loved one been injured by XYZ drug? You may be entitled to substantial compensation!”
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda.
The move to mainstream cancer advertising began several years ago with Bristol-Myers Squibb’s big TV campaign for Opdivo, followed by competitor Merck & Co. for its rival, Keytruda. Both put out broad and hopeful
“Drug warning!” blares the voice from a late-night TV ad. “Have you or a loved one been injured by XYZ drug? You may be entitled to substantial compensation!”